Hydrochlorothiazide/Triamterene and Losartan Interaction

Understanding the Hydrochlorothiazide/Triamterene and Losartan Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Hydrochlorothiazide/Triamterene belongs to the Thiazide / Potassium-Sparing Diuretic Combination class and Losartan belongs to the Angiotensin II Receptor Blocker (ARB) class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Both of these medicines can cause your body to hold onto too much potassium. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Hydrochlorothiazide/Triamterene has 13 total documented interactions on file in this dataset, and Losartan has 10. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor will need to monitor your potassium levels and kidney health with regular blood tests. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Hydrochlorothiazide/Triamterene or Losartan based on a web page, speak with your prescriber or pharmacist before making any change.